Back

Sudden death prevention and ICD therapy: unsolved issues - discussion

25 April 2021 (15:56 - 16:10)
Organised by:
Congress Presentation Part of: Sudden death prevention and ICD therapy: unsolved issues Prevention EHRA Premium Access EHRA 2021

4 More presentations in this session

Presentation thumbnail
Primary prevention in systolic dysfunction/heart failure patients: use, misuse, and underuse
Associate Professor M. Zabel (Goettingen, DE)
Slides Video
Presentation thumbnail
Antitachycardia pacing and VT termination: fact or fancy? What is the impact on shock reduction from a patient's perspective?
Doctor U. Birgersdotter-Green (La Jolla, US)
Slides Video
Presentation thumbnail
No more therapy delivery after ventricular tachycardia ablation? Will my patient fear shock again?
Doctor A. Berruezo Sanchez (Barcelona, ES)
Slides Video
Presentation thumbnail
Noninvasive risk factors for the prediction of inducibility on programmed ventricular stimulation in post-MI patients with ejection fraction over 40% at SCD risk, insights from the PRESERVE EF study
Doctor K. Trachanas (Athens, GR)
Slides Video

Access the full session

Session thumbnail
Sudden death prevention and ICD therapy: unsolved issues

The Event

Event poster

EHRA 2021

25 April 2021 15:56 CET
You may be interested in
thumbnail
Congress Session
Hot topics in the management of ventricular tachycardia and sudden cardiac death
1 April 2025
thumbnail
Congress Session
Atrioventricular block
1 April 2025
thumbnail
Congress Session
Ventricular arrhythmias and prevention of sudden cardiac death (6)
1 April 2025
thumbnail
Congress Presentation
Implantable cardioverter-defibrillator in patients with heart failure: real-world data on appropriate device therapy and survival in Greece
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources